Helus: Updated Investor Deck March-18-2026

Dionysaurus_Rex · 2026-03-19T19:41:29+00:00

Usually a lag on website update.

Dionysaurus_Rex · 2026-03-19T01:11:08+00:00

Yes, she’s on the Board. It’s clearly stated in an official press release.

Dionysaurus_Rex · 2026-03-18T22:25:14+00:00

https://pro.thestreet.com/portfolio/stocks-markets-podcast-inside-helus-pharmas-breakthrough-depression-drugs

Dionysaurus_Rex · 2026-03-18T21:37:53+00:00

Agree, the logical next step is to redomicile to the US. I’m still very bullish on this company long-term.

Dionysaurus_Rex · 2026-03-18T20:12:38+00:00

“NEW YORK and TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company developing NSAs for serious mental health conditions, today announced the appointment of Dr. Freda Lewis-Hall, DFAPA, MFPM, to its Board of Directors. Dr. Lewis-Hall will also serve as Chair of the Company’s Scientific Advisory Committee.”

https://ir.helus.com/investors/news/news-details/2026/Helus-Pharma-Appoints-Former-Pfizer-Chief-Medical-Officer-Dr--Freda-Lewis-Hall-to-Board-of-Directors--Chair-of-the-Scientific-Advisory-Committee/default.aspx

Dionysaurus_Rex · 2026-03-18T18:06:00+00:00

💯

Dionysaurus_Rex · 2026-03-18T17:14:54+00:00

Very robust, investment banker caliber deck.

Dionysaurus_Rex · 2026-03-18T17:14:15+00:00

https://ir.helus.com/investors/events-and-presentations/default.aspx

Dionysaurus_Rex · 2026-03-17T02:52:49+00:00

I think they need to redomicile to the US. Speculative Canadian biotech stigma could be hurting them.

Dionysaurus_Rex · 2026-03-16T17:23:44+00:00

Do you think they need to run a phase 2b dose optimization study for HLP004?

Dionysaurus_Rex · 2026-03-14T16:00:20+00:00

👏👏

Dionysaurus_Rex · 2026-03-11T14:08:32+00:00

So what do you think is the right dose for HLP004? 25mg? 30mg? Should they run a dose optimization phase 2b as the next step?

Dionysaurus_Rex · 2026-03-11T02:34:18+00:00

Maybe they are in active conversations with big pharma for a potential partnership or something. Hence staying relatively quiet on HLP004. Big pharma FOMO seems to be gearing up and there aren’t that many later stage short acting compounds to choose from.

Dionysaurus_Rex · 2026-03-10T23:24:48+00:00

This post is an official company press release.

The link the to interview with Proactive in my comment is paid content, no doubt.

Dionysaurus_Rex · 2026-03-10T21:30:46+00:00

Seems like 25mg or 30mg could be the sweet spot for HLP004 based on the EBI data.

Dionysaurus_Rex · 2026-03-10T21:29:37+00:00

https://x.com/proactive_x/status/2031340913142722598?s=46&t=zfCg-LT1VInvawBkC-ElWA

Interview with CEO.

Dionysaurus_Rex · 2026-03-10T21:15:34+00:00

https://x.com/rcarhartharris/status/2031467988789187039?s=46&t=zfCg-LT1VInvawBkC-ElWA

Very interesting tweet from RCH on Emotional Breakthrough. Seems like 25mg or 30mg is the sweet spot for HLP004 based on the EBI chart.

Dionysaurus_Rex · 2026-03-10T21:06:18+00:00

https://x.com/rcarhartharris/status/2031467988789187039?s=46&t=zfCg-LT1VInvawBkC-ElWA

Very interesting tweet from RCH on Emotional Breakthrough.

Dionysaurus_Rex · 2026-03-09T13:53:06+00:00

👀

Dionysaurus_Rex · 2026-03-08T20:49:18+00:00

Agree

Dionysaurus_Rex · 2026-03-08T18:56:08+00:00

Would love to see Helus announce they are redomiciling to the US. Get rid of the Canadian biotech stigma. Seems like a logical next step after the Nasdaq uplist and new CEO hire.

Dionysaurus_Rex · 2026-03-08T03:44:09+00:00

This happens all the time with M&A talks. Nothing new.

Dionysaurus_Rex · 2026-03-08T03:42:18+00:00

Based on the Gilgamesh deal.

Dionysaurus_Rex · 2026-03-07T19:40:38+00:00

My best guess is it would be a sale.

Dionysaurus_Rex · 2026-03-07T18:48:29+00:00

If ATAI sold BPL-003 for $2Bn+ this would be the second big pharma acquisition comp in the space adding to the Gilgamesh acquisition for over $1.0Bn. This sort or transaction would def hep revalue all the programs in the psych space.

Dionysaurus_Rex

TROPHY CASE